Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

Código QR

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

Thomas Wilke,1 Nils Picker,2 Sabrina Mueller,2 Silke Geier,3 Johannes Foersch,4 Jens Aberle,5 Stephan Martin,6 Matthias Riedl,7 Maximilian Gabler31IPAM, University of Wismar 23966 Wismar, Germany; 2Real-World Evidence and Health Economics, Ingress-Health HWM GmbH, Wismar 23966, Germany; 3HP Country...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	T2DM antidiabetic treatment claims data chart review Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/571aed618f8a412e82bb9220ab373dee
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
por: Wilke T, et al.
Publicado: (2019)

Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people
por: Xin YL, et al.
Publicado: (2019)

Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients
por: Tesfaye A, et al.
Publicado: (2020)

Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds
por: Nie X, et al.
Publicado: (2020)

TNF-α (−308) Gene Polymorphism and Type 2 Diabetes Mellitus in Ethiopian Diabetes Patients
por: Ayelign B, et al.
Publicado: (2019)

Facilitating Machine Learning Model Comparison and Explanation through a Radial Visualisation
por: Jianlong Zhou, et al.
Publicado: (2021)

A Comparative Prevalence Of Metabolic Syndrome Among Type 2 Diabetes Mellitus Patients In Hawassa University Comprehensive Specialized Hospital Using Four Different Diagnostic Criteria
por: Bizuayehu Wube T, et al.
Publicado: (2019)

Platelet Indices and Its Association with Microvascular Complications Among Type 2 Diabetes Mellitus Patients in Northeast Ethiopia: A Cross-Sectional Study
por: Taderegew MM, et al.
Publicado: (2021)

Effects of Topical Insulin on Wound Healing: A Review of Animal and Human Evidences
por: Wang J, et al.
Publicado: (2020)

Determinants and Prevalence of Impotence among Diabetic Patients in Northwestern Hospitals of Nefasit, Eretria
por: Degavi G, et al.
Publicado: (2021)

Diabetes Mellitus and Its Associated Factors in Tuberculosis Patients in Maekel Region, Eritrea: Analytical Cross-Sectional Study
por: Araia ZZ, et al.
Publicado: (2021)

Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa
por: Latiri I, et al.
Publicado: (2012)

Increased Serum Cystatin C Levels Were Associated with Depressive Symptoms in Patients with Type 2 Diabetes
por: Huang Y, et al.
Publicado: (2021)

Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia
por: Darraj H, et al.
Publicado: (2019)

Management Practice and Contributing Risk Factors for Chronic Complications Among Type 2 Diabetes Mellitus Adult Patients in Follow-Up at a Tertiary Care Teaching Hospital
por: Negash Z, et al.
Publicado: (2020)

Geniposide Balances the Redox Signaling to Mediate Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells
por: Liu C, et al.
Publicado: (2020)

Insulin initiation and intensification in patients with T2DM for the primary care physician
por: Unger J
Publicado: (2011)

The Hidden Burden of Diabetes Mellitus in an Urban Community of Southwest Ethiopia
por: Tesfaye Yunka T, et al.
Publicado: (2020)

Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry
por: Ivan Ivanovich Dedov, et al.
Publicado: (2017)

Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus
por: Gouda M, et al.
Publicado: (2018)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander PA
Publicado: (2012)

Association of adiponectin levels and insulin demand in critically ill patients
por: Andreas Hillenbrand, et al.
Publicado: (2011)

Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis
por: Suksomboon N, et al.
Publicado: (2017)

Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy
por: Habte ML, et al.
Publicado: (2020)

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra S
Publicado: (2010)

Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages
por: Hussein A, et al.
Publicado: (2020)

Teneligliptin in management of type 2 diabetes mellitus
por: Sharma SK, et al.
Publicado: (2016)

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Liu D, et al.
Publicado: (2021)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Stanley S Schwartz
Publicado: (2010)

Latent Autoimmune Diabetes in Adults (LADA) and its Metabolic Characteristics among Yemeni Type 2 Diabetes Mellitus Patients
por: Al-Zubairi T, et al.
Publicado: (2021)

The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
por: Carter J, et al.
Publicado: (2010)

Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
por: Almigbal TH
Publicado: (2021)

Predictors of Insulin Treatment During Pregnancy and Abnormal Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus
por: Tang L, et al.
Publicado: (2019)

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
por: Sikirica MV, et al.
Publicado: (2017)

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
por: Wang F, et al.
Publicado: (2012)

Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective
por: Wang Z, et al.
Publicado: (2020)

RELUCTANCE OF PATIENTS WITH DIABETES MELLITUS TO INSULIN THERAPY; PSYCHOLOGICAL INSULIN RESISTANCE
por: Umair Ali, et al.
Publicado: (2021)

Association of Dyslipidemia and Comorbidities with Risk Factors Among Diabetic Patients: A Retrospective Analysis
por: Gazzaz ZJ, et al.
Publicado: (2020)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)

In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
por: Melesie Taye G, et al.
Publicado: (2020)